Pfizer funds research and quality improvement projects to enhance care for elderly and complex HR+/HER2- metastatic breast cancer patients in Italy, focusing on real-world, patient-centered innovations.
Career Development Award in HER2 supports early-career pathologists conducting research to optimize and validate HER2 testing in solid tumors beyond breast and gastric cancer, improving patient selection.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
Investigator Sponsored Trials and Collaborative Studies support external researchers and Genmab’s study partners in clinical and preclinical research aimed at addressing unmet medical needs.
Areas of Interest (AOI) & Competitive Research Grants support independent investigators studying BMS products and early pipeline assets through scientific and clinical research to address unmet medical needs.